BiznisBroker about us | contact | members | job opportunities | bb news
Home Buy a Business FIND A PARTNER Invest in a business List your Company Find a Franchise FAQ  
Jul 30, 2010

US-based generic drug maker Mylan possibly bringing drug production to Hungary


Mylan is spending EUR 67m on a packaging plant in the Hungarian city of Komárom, National Economy Ministry state secretary Zsolt Becsey said at a press conference in Budapest .

“ needs such investments and such innovations that strengthen the Hungarian economy. Those do not destroy, but undisputedly build our country based on Hungarian small and medium-sized enterprises” - emphasized State Secretary for External Trade Relations of the Hungarian Government Zsolt Becsey at the investment announcement press conference on Thursday.

ambassador to Hungary Eleni Tsakopoulos said the fact had drawn USD 9bn in FDI from American investors since 1990 was a good sign of the country's ability to attract capital. 's geographic location, its good infrastructure and its well-educated, motivated and creative work force are a draw for US investors, she added.

“After conducting a broad search for a suitable facility with the potential to expand, the opportunity in Komárom turned out to be an ideal fit,” said Mylan chief operating officer Rajiv Malik. “Not long from now, we’ll have a high quality, efficient packaging operation up and running that will be able to support our dynamic business and the local economy."

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories.